Advances in biological regulation最新文献

{"title":"Biochemical basis for an interaction between SNX27 and the flexible SNX1 N-terminus","authors":"Mintu Chandra ,&nbsp;Brett M. Collins ,&nbsp;Lauren P. Jackson","doi":"10.1016/j.jbior.2021.100842","DOIUrl":"10.1016/j.jbior.2021.100842","url":null,"abstract":"<div><p><span><span>Metazoans require the sorting nexin (SNX) protein, </span>SNX27<span><span>, to recycle hundreds of important transmembrane protein receptors from endosomes to the plasma membrane. Cargo recycling by SNX27 requires its interaction with </span>retromer<span>, a heterotrimer known to assemble on membranes with multiple sorting nexins, including SNX-BAR proteins and SNX3<span>. SNX27 has also been functionally linked to SNX-BARs, but the molecular basis of this interaction has been unknown. We identify a direct biochemical interaction between the conserved and flexible SNX1/SNX2 N-terminus and full-length SNX27 using purified proteins in pulldown experiments. Sequence alignments<span> indicate both SNX1 and SNX2 contain two short and conserved stretches of acidic residues bearing a DxF motif in their flexible N-terminal regions. Biochemical pulldown and mapping experiments reveal forty residues in the N-terminus of either SNX1 or SNX2 can mediate binding to SNX27. SNX27 truncation analysis demonstrates the SNX27 FERM domain<span> binds the SNX1 N-terminus. Calorimetry experiments quantified binding between the SNX1 N-terminus and SNX27 in the low micromolar affinity range (K</span></span></span></span></span></span>_D ∼10 μM) and suggest the second DxF motif may play a more prominent role in binding. Mutation of either DxF sequence in SNX1 abrogates measurable binding to SNX27 in the calorimeter. Modelling from both predicted and experimentally determined structures suggests the SNX27 FERM domain could accommodate both DxF motifs simultaneously. Together, these data suggest SNX27 is directly linked to specific SNX-BAR proteins through binding acidic motifs in the SNX1 or SNX2 N-terminus.</p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100842"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The inositol pyrophosphate metabolism of Dictyostelium discoideum does not regulate inorganic polyphosphate (polyP) synthesis","authors":"Yann Desfougères ,&nbsp;Paloma Portela-Torres ,&nbsp;Danye Qiu ,&nbsp;Thomas M. Livermore ,&nbsp;Robert K. Harmel ,&nbsp;Filipy Borghi ,&nbsp;Henning J. Jessen ,&nbsp;Dorothea Fiedler ,&nbsp;Adolfo Saiardi","doi":"10.1016/j.jbior.2021.100835","DOIUrl":"10.1016/j.jbior.2021.100835","url":null,"abstract":"<div><p>Initial studies on the inositol phosphates metabolism were enabled by the social amoeba <em>Dictyostelium discoideum.</em> The abundant amount of inositol hexakisphosphate (IP₆ also known as Phytic acid) present in the amoeba allowed the discovery of the more polar inositol pyrophosphates, IP₇ and IP₈, possessing one or two high energy phosphoanhydride bonds, respectively. Considering the contemporary growing interest in inositol pyrophosphates, it is surprising that in recent years <em>D. discoideum</em>, has contributed little to our understanding of their metabolism and function. This work fulfils this lacuna, by analysing the <em>ip6k, ppip5k</em> and <em>ip6k-ppip5K</em> amoeba null strains using PAGE, ¹³C-NMR and CE-MS analysis. Our study reveals an inositol pyrophosphate metabolism more complex than previously thought. The amoeba Ip6k synthesizes the 4/6-IP₇ in contrast to the 5-IP₇ isomer synthesized by the mammalian homologue. The amoeba Ppip5k synthesizes the same 1/3-IP₇ as the mammalian enzyme. In <em>D. discoideum</em>, the <em>ip6k</em> strain possesses residual amounts of IP₇. The residual IP₇ is also present in the <em>ip6k-ppip5K</em> strain, while the <em>ppip5k</em> single mutant shows a decrease in both IP₇ and IP₈ levels. This phenotype is in contrast to the increase in IP₇ observable in the yeast <em>vip1</em>Δ strain. The presence of IP₈ in <em>ppip5k</em> and the presence of IP₇ in <em>ip6k-ppip5K</em> indicate the existence of an additional inositol pyrophosphate synthesizing enzyme. Additionally, we investigated the existence of a metabolic relationship between inositol pyrophosphate synthesis and inorganic polyphosphate (polyP) metabolism as observed in yeast. These studies reveal that contrary to the yeast, Ip6k and Ppip5k do not control polyP cellular level in amoeba.</p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100835"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885430/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39627613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mechanistic roles of mutant p53 governing lipid metabolism","authors":"Ryan M. Loughran,&nbsp;Brooke M. Emerling","doi":"10.1016/j.jbior.2021.100839","DOIUrl":"10.1016/j.jbior.2021.100839","url":null,"abstract":"<div><p>Metabolic reprogramming of cancer cells by various acquired mutations provides support for rapid proliferation and growth in the tumor microenvironment. Mutations in the <em>TP53</em><span><span><span> gene are the most common mutation found across all human cancers. Commonly referred to as “the guardian of the genome”, p53 has a well-established role as a tumor suppressor by mediating checkpoint integrity and protecting cells from DNA damage. To date, the many functional roles of p53 extending beyond its classical function and exerting control over metabolic processes continues to confound the field. Recently, emerging roles for p53 in mediating lipid metabolism have come to light with intriguing metabolic roles in regulating cholesterol </span>homeostasis<span> and lipid droplet<span> formation. Herein, we will seek to unify the mechanisms by which absence of functional p53, as well as stable mutant forms of p53, exert control over these lipid metabolism programs. Of equal importance, synthetic lethal phenotypes in the context of mutant p53 and aberrant lipid homeostasis offer new possible targets in the therapeutic landscape. This review aims to characterize the mechanisms by which p53 exerts control over these pathways and examine how precision medicine may benefit from tumor </span></span></span>subtyping of p53 mutations.</span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100839"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10824743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Elusive structure of mammalian DGKs","authors":"Qianqian Ma ,&nbsp;Lakshmi Srinivasan ,&nbsp;Sandra B. Gabelli ,&nbsp;Daniel M. Raben","doi":"10.1016/j.jbior.2021.100847","DOIUrl":"10.1016/j.jbior.2021.100847","url":null,"abstract":"<div><p><span><span>Mammalian diacylglycerol kinases (DGKs) are a group of </span>enzymes<span> that catalyze the ATP-dependent phosphorylation of diacylglycerol (DAG) to produce phosphatidic acid (PtdOH). In doing so, they modulate the levels of these two important </span></span>signaling lipids. Currently, ten mammalian DGKs are organized into five classes that vary with respect to domain organization, regulation, and cellular/subcellular distribution.</p><p>As lipids<span> play critical roles in cells, it is not surprising that there is increasing interest in understanding the mechanism underlying the catalysis and regulation of lipid modulating enzymes such as DGKs. However, there are no solved 3D structures for any of the eukaryotic DGKs. In this review, we summarize what is known and the current challenges in determining the structures of these important enzymes. In addition to gain critical insights into their mechanisms of catalysis and regulation, DGK structures will provide a platform for the design of isoform specific inhibitors.</span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100847"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10456866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"List of Participants","authors":"","doi":"10.1016/S2212-4926(22)00008-2","DOIUrl":"https://doi.org/10.1016/S2212-4926(22)00008-2","url":null,"abstract":"","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100868"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2212492622000082/pdfft?md5=c899dab14078dc09033790b8dc90cbaa&pid=1-s2.0-S2212492622000082-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138374742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Phosphoinositide 3-kinase signalling in the nucleolus","authors":"Andrea Papdiné Morovicz,&nbsp;Fatemeh Mazloumi Gavgani,&nbsp;Rhîan G. Jacobsen,&nbsp;Malene Skuseth Slinning,&nbsp;Diana C. Turcu,&nbsp;Aurélia E. Lewis","doi":"10.1016/j.jbior.2021.100843","DOIUrl":"10.1016/j.jbior.2021.100843","url":null,"abstract":"<div><p>The phosphoinositide 3-kinase (PI3K) signalling pathway<span><span> plays key roles in many cellular processes and is altered in many diseases. The function and mode of action of the pathway have mostly been elucidated in the cytoplasm. However, many of the components of the PI3K pathway are also present in the nucleus at specific sub-nuclear sites including nuclear speckles, nuclear lipid islets and the </span>nucleolus<span>. Nucleoli are membrane-less subnuclear structures where ribosome biogenesis<span> occurs. Processes leading to ribosome biogenesis are tightly regulated to maintain protein translation capacity of cells. This review focuses on nucleolar PI3K signalling and how it regulates rRNA synthesis, as well as on the identification of downstream phosphatidylinositol (3,4,5)trisphosphate effector proteins.</span></span></span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100843"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39612450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacological tools to investigate inositol polyphosphate kinases – Enzymes of increasing therapeutic relevance","authors":"Tim Kröber ,&nbsp;Simon M. Bartsch ,&nbsp;Dorothea Fiedler","doi":"10.1016/j.jbior.2021.100836","DOIUrl":"10.1016/j.jbior.2021.100836","url":null,"abstract":"<div><p>Inositol<span> poly- and pyrophosphates<span> (InsPs and PP-InsPs) are a group of central eukaryotic metabolites and signaling molecules. Due to the diverse cellular functions and widespread diseases InsPs and PP-InsPs are associated with, pharmacological targeting of the kinases involved in their biosynthesis<span> has become a significant research interest in the last decade. In particular, the development of inhibitors for inositol hexakisphosphate kinases (IP6Ks) has leaped forward, while other inositol phosphate kinases have received scant attention.</span></span></span></p><p>This review summarizes the efforts undertaken so far for discovering potent and selective inhibitors for this diverse group of small molecule kinases. The benefits of pharmacological inhibition are highlighted, given the multiple kinase-independent functions of inositol phosphate kinases. The distinct structural families of InsP and PP-InsP kinases are presented, and we discuss how compound availability for different inositol phosphate kinase families varies drastically. Lead compound discovery and optimization for the inositol kinases would benefit from detailed structural information on the ATP-binding sites of these kinases, as well as reliable biochemical and cellular read-outs to monitor inositol phosphate kinase activity in complex settings. Efforts to further tune well-established inhibitors, while simultaneously reviving tool compound development for the more neglected kinases from this family are indisputably worthwhile, considering the large potential therapeutic benefits.</p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100836"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39731854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of the MDM2 inhibitor Nutlin-3a on sensitivity of pancreatic cancer cells to berberine and modified berberines in the presence and absence of WT-TP53","authors":"Stephen L. Abrams ,&nbsp;Shaw M. Akula ,&nbsp;Linda S. Steelman ,&nbsp;Matilde L. Follo ,&nbsp;Lucio Cocco ,&nbsp;Stefano Ratti ,&nbsp;Alberto M. Martelli ,&nbsp;Massimo Libra ,&nbsp;Luca Falzone ,&nbsp;Saverio Candido ,&nbsp;Giuseppe Montalto ,&nbsp;Melchiorre Cervello ,&nbsp;Paolo Lombardi ,&nbsp;James A. McCubrey","doi":"10.1016/j.jbior.2021.100840","DOIUrl":"10.1016/j.jbior.2021.100840","url":null,"abstract":"<div><p><span>Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Approximately 80% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC). A key regulatory gene frequently mutated (∼75%) in PDAC is the </span><em>TP53</em><span><span> tumor suppressor gene<span> which controls the transcription of multiple genes involved in cell cycle progression, apoptosis, cancer progression and other growth regulatory processes. The mouse double minute 2 homolog (MDM2) gene product is a nuclear-localized E3 </span></span>ubiquitin ligase<span> and negatively regulates the TP53 protein which results in its proteasomal degradation. Various MDM2 inhibitors have been isolated and examined in clinical trials, especially in patients with hematological malignancies. Nutlin-3a is one of the first MDM2 inhibitors isolated. Berberine (BBR) is a natural product found in many fruits and berries and used in traditional medicine for centuries. It has many biological effects, and some are anti-proliferative in nature. BBR may activate the expression of TP53 and inhibit cell cycle progression as well as other events important in cell growth. To understand more about the potential of compounds like BBR and chemical modified BBRs (NAX compounds) to sensitize PDAC cells to MDM2 inhibitors, we introduced either WT-TP53 or the pLXSN empty vector control into two PDAC cell lines, one lacking expression of TP53 (PANC-28) and one with gain-of-function mutant TP53 on both alleles (MIA-PaCa-2). Our results indicate that nutlin-3a was able to increase the sensitivity to BBR and certain NAX compounds. The effects of nutlin-3a were usually more substantial in those cells containing an introduced WT TP53 gene. These results highlight the importance of knowledge of the type of TP53 mutation that is present in cancer patients before the administration of drugs which function by stabilization of the TP53 protein.</span></span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100840"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39961007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rapid testing of candidate oncogenes and tumour suppressor genes in signal transduction and neoplastic transformation","authors":"Sha Liu ,&nbsp;Paula Medina-Perez ,&nbsp;Minh-Cam Ha-Thi ,&nbsp;Anja Wieland ,&nbsp;Maria Stecklum ,&nbsp;Jens Hoffmann ,&nbsp;Oleg Tchernitsa ,&nbsp;Christine Sers ,&nbsp;Reinhold Schäfer","doi":"10.1016/j.jbior.2021.100841","DOIUrl":"10.1016/j.jbior.2021.100841","url":null,"abstract":"<div><p><span>The COSMIC database (version 94) lists 576 genes in the Cancer Gene Census which have a defined function as drivers of malignancy (oncogenes) or as tumour suppressors<span> (Tier 1). In addition, there are 147 genes with similar functions, but which are less well characterised (Tier 2). Furthermore, next-generation sequencing projects in the context of precision oncology activities are constantly discovering new ones. Since cancer genes differ from their wild-type precursors in numerous molecular and biochemical properties and exert significant differential effects on downstream processes, simple assays that can uncover oncogenic or anti-oncogenic functionality are desirable and may precede more sophisticated analyses. We describe simple functional assays for PTPN11 (protein-tyrosine phosphatase, non-receptor-type 11)/SHP2 mutants, which are typically found in RASopathies and exhibit potential oncogenic activity. We have also designed a functional test for lysyl oxidase<span> (LOX), a prototypical class II tumour suppressor gene whose loss of function may contribute to neoplastic transformation by RAS </span></span></span>oncogenes. Moreover, we applied this test to analyse three co-regulated, RAS-responsive genes for transformation-suppressive activity. The integration of these tests into systems biology studies will contribute to a better understanding of cellular networks in cancer.</p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100841"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39961008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pathophysiological role of 27-hydroxycholesterol in human diseases","authors":"Dayea Kim ,&nbsp;Kwang Min Lee ,&nbsp;Chanhee Lee ,&nbsp;Yeon Suk Jo ,&nbsp;Muradillaeva Shakhnoza Muradillaevna ,&nbsp;Jae Ho Kim ,&nbsp;Jong Hyuk Yoon ,&nbsp;Parkyong Song","doi":"10.1016/j.jbior.2021.100837","DOIUrl":"10.1016/j.jbior.2021.100837","url":null,"abstract":"<div><p>Oxysterols<span><span><span><span> are oxygenated cholesterol derivatives and important regulators of cholesterol metabolism<span>, lipid homeostasis, the immune system, and </span></span>membrane fluidity<span> regulation. Although the detailed mechanism of action of oxysterols remains unclear, activation of some nuclear receptors<span>, such as liver X receptor α (LXRα) and RAR-related orphan receptors, have been believed to be critical for the regulation of various </span></span></span>physiological processes<span> in multiple tissues. 27-Hydroxycholesterol (27-OHC) is an endogenous oxysterol, which has an intermediate function in cholesterol catabolism to bile acid synthesis<span>. According to previous studies, however, there are opposing opinions on whether 27-OHC activates human LXR. Recently, several studies have shown that 27-OHC can activate or inhibit the function of </span></span></span>estrogen receptors ERα and ERβ in a tissue-specific manner, indicating that the understanding of 27-OHC-mediated biological output is very complicated. This review summarizes the pathophysiological relevance of 27-OHC in various tissues, with a special discussion on their functions in human diseases.</span></p></div>","PeriodicalId":7214,"journal":{"name":"Advances in biological regulation","volume":"83 ","pages":"Article 100837"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39621310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}